UniProt ID | LY9_HUMAN | |
---|---|---|
UniProt AC | Q9HBG7 | |
Protein Name | T-lymphocyte surface antigen Ly-9 | |
Gene Name | LY9 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 655 | |
Subcellular Localization |
Membrane Single-pass type I membrane protein. Cell membrane . |
|
Protein Description | Self-ligand receptor of the signaling lymphocytic activation molecule (SLAM) family. SLAM receptors triggered by homo- or heterotypic cell-cell interactions are modulating the activation and differentiation of a wide variety of immune cells and thus are involved in the regulation and interconnection of both innate and adaptive immune response. Activities are controlled by presence or absence of small cytoplasmic adapter proteins, SH2D1A/SAP and/or SH2D1B/EAT-2. May participate in adhesion reactions between T lymphocytes and accessory cells by homophilic interaction. Promotes T-cell differentiation into a helper T-cell Th17 phenotype leading to increased IL-17 secretion; the costimulatory activity requires SH2D1A. [PubMed: 22184727 Promotes recruitment of RORC to the IL-17 promoter] | |
Protein Sequence | MVAPKSHTDDWAPGPFSSKPQRSQLQIFSSVLQTSLLFLLMGLRASGKDSAPTVVSGILGGSVTLPLNISVDTEIENVIWIGPKNALAFARPKENVTIMVKSYLGRLDITKWSYSLCISNLTLNDAGSYKAQINQRNFEVTTEEEFTLFVYEQLQEPQVTMKSVKVSENFSCNITLMCSVKGAEKSVLYSWTPREPHASESNGGSILTVSRTPCDPDLPYICTAQNPVSQRSSLPVHVGQFCTDPGASRGGTTGETVVGVLGEPVTLPLALPACRDTEKVVWLFNTSIISKEREEAATADPLIKSRDPYKNRVWVSSQDCSLKISQLKIEDAGPYHAYVCSEASSVTSMTHVTLLIYRRLRKPKITWSLRHSEDGICRISLTCSVEDGGNTVMYTWTPLQKEAVVSQGESHLNVSWRSSENHPNLTCTASNPVSRSSHQFLSENICSGPERNTKLWIGLFLMVCLLCVGIFSWCIWKRKGRCSVPAFCSSQAEAPADTPEPTAGHTLYSVLSQGYEKLDTPLRPARQQPTPTSDSSSDSNLTTEEDEDRPEVHKPISGRYEVFDQVTQEGAGHDPAPEGQADYDPVTPYVTEVESVVGENTMYAQVFNLQGKTPVSQKEESSATIYCSIRKPQVVPPPQQNDLEIPESPTYENFT | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
34 | Phosphorylation | IFSSVLQTSLLFLLM HHHHHHHHHHHHHHH | 19.72 | 26552605 | |
35 | Phosphorylation | FSSVLQTSLLFLLMG HHHHHHHHHHHHHHH | 15.32 | 26552605 | |
46 | Phosphorylation | LLMGLRASGKDSAPT HHHHHHHCCCCCCCC | 39.68 | 26552605 | |
68 | N-linked_Glycosylation | GSVTLPLNISVDTEI CEEEEECEEEECCCE | 23.66 | UniProtKB CARBOHYD | |
95 | N-linked_Glycosylation | AFARPKENVTIMVKS EECCCCCCEEEEEEH | 42.21 | 19349973 | |
95 | N-linked_Glycosylation | AFARPKENVTIMVKS EECCCCCCEEEEEEH | 42.21 | 19349973 | |
97 | Phosphorylation | ARPKENVTIMVKSYL CCCCCCEEEEEEHHH | 18.22 | 25690035 | |
102 | Phosphorylation | NVTIMVKSYLGRLDI CEEEEEEHHHCCCCC | 17.74 | 29759185 | |
103 | Phosphorylation | VTIMVKSYLGRLDIT EEEEEEHHHCCCCCH | 13.88 | 23532336 | |
110 | Phosphorylation | YLGRLDITKWSYSLC HHCCCCCHHHEEEEE | 26.57 | 29759185 | |
120 | N-linked_Glycosylation | SYSLCISNLTLNDAG EEEEEEECCEECCCC | 19.68 | UniProtKB CARBOHYD | |
159 (in isoform 4) | Phosphorylation | - | 9.15 | 27251275 | |
160 | Phosphorylation | QLQEPQVTMKSVKVS HHCCCEEEEEEEEEC | 17.40 | - | |
163 | Phosphorylation | EPQVTMKSVKVSENF CCEEEEEEEEECCCC | 19.15 | - | |
169 | N-linked_Glycosylation | KSVKVSENFSCNITL EEEEECCCCCCEEEE | 26.99 | UniProtKB CARBOHYD | |
173 | N-linked_Glycosylation | VSENFSCNITLMCSV ECCCCCCEEEEEEEE | 29.13 | UniProtKB CARBOHYD | |
186 | Phosphorylation | SVKGAEKSVLYSWTP EECCCCEEEEEEECC | 14.62 | - | |
248 | Phosphorylation | FCTDPGASRGGTTGE EECCCCCCCCCCCCC | 37.06 | - | |
285 | N-linked_Glycosylation | EKVVWLFNTSIISKE HHEEEEEECCCCCHH | 30.65 | 19349973 | |
285 | N-linked_Glycosylation | EKVVWLFNTSIISKE HHEEEEEECCCCCHH | 30.65 | 19349973 | |
287 | Phosphorylation | VVWLFNTSIISKERE EEEEEECCCCCHHHH | 21.01 | 24719451 | |
298 | O-linked_Glycosylation | KEREEAATADPLIKS HHHHHHHHCCCCCCC | 38.34 | OGP | |
304 | Ubiquitination | ATADPLIKSRDPYKN HHCCCCCCCCCCCCC | 47.31 | - | |
309 | Phosphorylation | LIKSRDPYKNRVWVS CCCCCCCCCCCEEEE | 25.78 | 18083107 | |
325 | Phosphorylation | QDCSLKISQLKIEDA CCCEEEEEECEECCC | 28.07 | 24719451 | |
368 | Phosphorylation | RKPKITWSLRHSEDG CCCCEEEEEECCCCC | 13.58 | 24719451 | |
406 | Phosphorylation | LQKEAVVSQGESHLN CCCEEEECCCCCCCE | 26.35 | 25850435 | |
410 | Phosphorylation | AVVSQGESHLNVSWR EEECCCCCCCEEEEE | 39.85 | 25850435 | |
413 | N-linked_Glycosylation | SQGESHLNVSWRSSE CCCCCCCEEEEECCC | 21.98 | UniProtKB CARBOHYD | |
415 | Phosphorylation | GESHLNVSWRSSENH CCCCCEEEEECCCCC | 18.72 | 25850435 | |
424 | N-linked_Glycosylation | RSSENHPNLTCTASN ECCCCCCCCEEEECC | 40.19 | UniProtKB CARBOHYD | |
508 | Phosphorylation | PTAGHTLYSVLSQGY CCCCHHHHHHHHCCH | 9.63 | - | |
509 | Phosphorylation | TAGHTLYSVLSQGYE CCCHHHHHHHHCCHH | 21.50 | - | |
512 | Phosphorylation | HTLYSVLSQGYEKLD HHHHHHHHCCHHCCC | 21.28 | - | |
515 | Phosphorylation | YSVLSQGYEKLDTPL HHHHHCCHHCCCCCC | 11.40 | - | |
520 | Phosphorylation | QGYEKLDTPLRPARQ CCHHCCCCCCCCCCC | 34.36 | - | |
560 | Phosphorylation | HKPISGRYEVFDQVT CCCCCCCEEEEEHHC | 21.70 | - | |
583 | Phosphorylation | APEGQADYDPVTPYV CCCCCCCCCCCCCCE | 25.76 | - | |
589 | Phosphorylation | DYDPVTPYVTEVESV CCCCCCCCEEEEEEE | 15.61 | - | |
603 | Phosphorylation | VVGENTMYAQVFNLQ ECCCCCEEEEEEECC | 7.58 | 10970093 | |
613 | Phosphorylation | VFNLQGKTPVSQKEE EEECCCCCCCCCCCC | 35.43 | 24706070 | |
616 | Phosphorylation | LQGKTPVSQKEESSA CCCCCCCCCCCCCCC | 36.42 | 24706070 | |
621 | Phosphorylation | PVSQKEESSATIYCS CCCCCCCCCCEEEEE | 26.77 | 26552605 | |
622 | Phosphorylation | VSQKEESSATIYCSI CCCCCCCCCEEEEEE | 32.48 | 26552605 | |
624 | Phosphorylation | QKEESSATIYCSIRK CCCCCCCEEEEEECC | 17.90 | 28796482 | |
626 | Phosphorylation | EESSATIYCSIRKPQ CCCCCEEEEEECCCC | 3.93 | 28796482 | |
628 | Phosphorylation | SSATIYCSIRKPQVV CCCEEEEEECCCCCC | 14.41 | 28796482 | |
648 | Phosphorylation | NDLEIPESPTYENFT CCCCCCCCCCCCCCC | 19.72 | 28796482 | |
650 | Phosphorylation | LEIPESPTYENFT-- CCCCCCCCCCCCC-- | 53.39 | 28796482 | |
651 | Phosphorylation | EIPESPTYENFT--- CCCCCCCCCCCC--- | 16.56 | 28796482 | |
655 | Phosphorylation | SPTYENFT------- CCCCCCCC------- | 49.65 | 28796482 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of LY9_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LY9_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LY9_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
AP2M1_HUMAN | AP2M1 | physical | 12621057 | |
PTN11_HUMAN | PTPN11 | physical | 11689425 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins."; Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,Schiess R., Aebersold R., Watts J.D.; Nat. Biotechnol. 27:378-386(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-285, AND MASSSPECTROMETRY. |